ACME UNITED CORP ACU
Acme United Corporation, a Connecticut corporation (together, with its subsidiaries, the "Company"), is a leading worldwide supplier of innovative first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, and sharpening tools. The Company sells its products primarily to mass market and e-commerce retailers, industrial distributors, wholesale, contract and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains.
The Company's operations are in the United States, Canada, Europe (located in Germany) and Asia (located in Hong Kong and China). The operations in the United States, Canada and Europe are primarily involved in product development, marketing, sales, administrative, manufacturing and distribution activities. The operations in Asia consist of sourcing, product development, production planning, quality control and sales activities. Total net sales in 2025 were $196.5 million. The Company was organized as a partnership in l867 and incorporated in l882 under the laws of the State of Connecticut.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- United States
- Europe
- Canada
- Other
| Region | FY2025 | FY2024 |
|---|---|---|
| United States | $164.1M | $165.1M |
| Europe | $16.3M | $15.1M |
| Canada | $15.1M | $13.3M |
| Other | $1.1M | $1.1M |
As the company reported it, from the “Segment Information - Segment Revenues (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Revenue by segment
- United States Segment
- Europe Segment
- Canada Segment
| Segment | FY2025 | FY2024 |
|---|---|---|
| United States Segment | $165.1M | $166.2M |
| Europe Segment | $16.3M | $15.1M |
| Canada Segment | $15.1M | $13.3M |
As the company reported it, from the “Segment Information - Financial Data by Segment (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $196.5M | $194.5M | $191.5M | $194.0M | $182.1M | $164.0M | $142.5M | $137.3M | $130.6M | $124.6M |
| Cost of revenue | $119.1M | $118.1M | $119.3M | $130.4M | $117.3M | $104.4M | $90.5M | $86.7M | $82.7M | $79.0M |
| Gross profit | $77.4M | $76.4M | $72.2M | $63.6M | $64.8M | $59.6M | $52.0M | $50.6M | $47.9M | $45.6M |
| R&D | — | — | — | — | — | $251.0K | $596.0K | $734.0K | $752.0K | $750.0K |
| SG&A | $62.7M | $62.2M | $59.0M | $57.3M | $52.0M | $48.2M | $43.6M | $43.2M | $40.0M | $37.1M |
| Operating income | $14.7M | $14.1M | $13.2M | $6.3M | $12.8M | $11.4M | $8.4M | $7.5M | $7.9M | $8.4M |
| Interest expense | — | — | $3.0M | $2.4M | $908.2K | $919.7K | $1.8M | $1.9M | $1.3M | $868.5K |
| Pre-tax income | $13.1M | $12.3M | $22.7M | $3.7M | $15.2M | $9.8M | $6.5M | $5.5M | $6.5M | $7.5M |
| Income tax | $2.9M | $2.3M | $4.9M | $627.7K | $1.5M | $1.7M | $1.0M | $932.9K | $2.4M | $1.6M |
| Net income | $10.2M | $10.0M | $17.8M | $3.0M | $13.7M | $8.1M | $5.5M | $4.6M | $4.1M | $5.9M |
| EPS, basic | 2.69 | 2.71 | 4.98 | 0.86 | 3.93 | 2.42 | 1.65 | 1.36 | 1.21 | 1.76 |
| EPS, diluted | 2.49 | 2.45 | 4.86 | 0.82 | 3.45 | 2.31 | 1.60 | 1.30 | 1.09 | 1.64 |
| Shares, diluted (wtd. avg.) | 4.1M | 4.1M | 3.7M | 3.7M | 4.0M | 3.5M | 3.5M | 3.5M | 3.7M | 3.6M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.6M | $6.4M | $5.5M | $7.6M | $4.8M | $4.2M | $6.8M | $4.4M | $9.3M | $5.9M |
| Receivables | $29.1M | $28.2M | $26.2M | $32.6M | $34.2M | $27.2M | $25.5M | $25.1M | $26.0M | $20.0M |
| Inventory | $59.9M | $56.3M | $55.5M | $63.3M | $53.6M | $50.7M | $39.3M | $41.3M | $40.1M | $37.2M |
| Total current assets | $96.2M | $95.5M | $92.0M | $105.6M | $95.3M | $83.7M | $73.1M | $73.0M | $77.8M | $65.0M |
| Property, plant and equipment | $38.5M | $31.7M | $28.0M | $26.4M | $24.0M | $20.2M | $14.0M | $14.5M | $13.7M | $8.0M |
| Goodwill | $9.9M | $9.9M | $8.2M | $8.2M | $4.8M | $4.8M | $4.7M | $4.7M | $4.7M | $3.9M |
| Other intangibles | $19.5M | $20.3M | $19.0M | $20.8M | $17.2M | $18.7M | $15.8M | $17.0M | $17.9M | $14.0M |
| Total assets | $171.0M | $162.2M | $149.2M | $164.4M | $144.4M | $129.9M | $110.7M | $109.5M | $114.7M | $92.1M |
| Accounts payable | $8.1M | $9.0M | $12.1M | $10.5M | $9.0M | $7.6M | $6.7M | $8.0M | $11.2M | $7.3M |
| Total current liabilities | $22.9M | $22.9M | $26.0M | $22.1M | $20.3M | $20.2M | $16.6M | $13.4M | $16.8M | $12.8M |
| Long-term debt | $11.9M | $17.6M | $13.1M | $49.9M | $33.0M | $38.8M | $33.2M | $40.3M | $43.5M | $32.9M |
| Total liabilities | $53.4M | $55.2M | $51.3M | $85.3M | $67.4M | $67.2M | $55.0M | $57.1M | $64.8M | $45.9M |
| Retained earnings | $102.3M | $94.5M | $86.7M | $71.0M | $69.9M | $58.0M | $51.6M | $47.5M | $44.5M | $41.9M |
| Total equity | $117.6M | $107.0M | $97.9M | $79.0M | $77.1M | $62.7M | $55.7M | $52.3M | $49.9M | $46.1M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.2M | $12.0M | $28.9M | $2.9M | $5.1M | $5.7M | $14.7M | $4.5M | $4.8M | $8.9M |
| Depreciation and amortisation | $3.8M | $3.5M | $3.0M | $2.8M | $2.6M | $2.4M | $2.2M | $2.0M | $1.7M | $1.5M |
| Stock-based compensation | $2.0M | $2.2M | $1.9M | $1.8M | $1.8M | $1.3M | $968.5K | $869.1K | $684.4K | $440.5K |
| Capital expenditure | $10.7M | $7.1M | $4.7M | $4.3M | $6.4M | $2.6M | $1.7M | $2.9M | $3.1M | $1.8M |
| Investing cash flow | -$12.3M | -$12.9M | $7.4M | -$14.2M | -$6.4M | -$14.0M | -$1.7M | -$3.2M | -$14.4M | -$8.8M |
| Financing cash flow | -$8.9M | $2.0M | -$38.4M | $14.3M | $2.0M | $5.3M | -$10.6M | -$6.1M | $12.9M | $3.5M |
| Dividends paid | $2.3M | $2.2M | $2.0M | $1.9M | $1.8M | $1.6M | $1.6M | $1.5M | $1.4M | $1.3M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-102079.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124.6M | $130.6M | $137.3M | $142.5M | $164.0M | $182.1M | $194.0M | $191.5M | $194.5M | $196.5M |
| Gross profit | $45.6M | $47.9M | $50.6M | $52.0M | $59.6M | $64.8M | $63.6M | $72.2M | $76.4M | $77.4M |
| Net income | $5.9M | $4.1M | $4.6M | $5.5M | $8.1M | $13.7M | $3.0M | $17.8M | $10.0M | $10.2M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Material agreement signed Item 1.01
- Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
- Results announced Item 2.02
- Results announced Item 2.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3420
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| SNA | Snap-on Inc | $18.47B | 18.6x | 0.7% |
| SWK | STANLEY BLACK & DECKER, INC. | $14.99B | 37.4x | -1.5% |
| SSD | Simpson Manufacturing Co., Inc. | $7.56B | 22.4x | 4.5% |
| HLMN | Hillman Solutions Corp. | $1.40B | 36.0x | 5.4% |
| CIX | COMPX INTERNATIONAL INC | $445.4M | 22.8x | 8.5% |
| LCUT | LIFETIME BRANDS, INC | $193.6M | — | -5.1% |
| EML | EASTERN CO | $145.5M | 20.7x | -8.7% |
| RECT | Rectitude Holdings Ltd. | — | — | 22.0% |